Cambrex (CBM) Return on Assets ROA from the third quarter of 2019 to third quarter of 2018 and for the year 2019, Average High and Low, Fundamental Ratios from Sep 30 2019 to Sep 30 2018 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Cambrex Corp  (CBM)


Cambrex's ROA from the third quarter of 2019 to the third quarter of 2018 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Cambrex's ROA in the third quarter of 2019?
Cambrex Corp achieved a return on average assets (ROA) of 2.57 % in its third quarter of 2019, which is below Cambrex's average return on assets, which stands at 12.15%.

ROA decreased relative to the period ending Jun 30 2019, due to the decline in net income.

However, within the Healthcare sector 167 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the second quarter of 2019 from 1071 to 1526.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter
Y / Y Total Assets Change 20.73 % 82.42 % 86.98 % 65.2 % 78.69 %
Y / Y Net Income Change -64.29 % -61.36 % -56.73 % -96.99 % 54.54 %
Net Income (TTM) in million 37 54 79 92 131
Return On Assets (TTM) 2.57 % 3.94 % 6.58 % 9.02 % 14.54 %
CBM's Total Ranking # 1526 # 1071 # 874 # 382 # 329
Total Assets (TTM) in million 1,507 1,516 1,489 1,223 1,248
Seq. Total Assets Change -0.61 % 1.81 % 21.69 % -1.96 % 50.19 %
Seq. Net Income Change -38.88 % 50.04 % 758.83 % -95.47 % -33.87 %

CBM's 5 Years Annual ROA >> Back to CBM Management Effectiveness >> Compare CBM ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 63
Sector # 168
Overall # 1802

Return On Assets Statistics
High Average Low
17.94 %
12.15 %
2.57 %
(Mar 31 2013)   (Sep 30 2019)





Financial Statements
Cambrex's Assets $ 1,507 million CBM's Balance sheet
Cambrex's Income $ 10 million Quarterly CBM's Income Statement
CBM's Income by Division See CBM's Income by Division



Annual Return On Assets (Dec 31 2018)
FY 2018		 (Dec 31 2017)
FY 2017		 (Dec 31 2016)
FY 2016		 (Dec 31 2015)
FY 2015		 (Dec 31 2014)
FY 2014
Y / Y Total Assets Change 65.2 % 21.03 % 21.03 % 3.79 % 6.34 %
Total Assets in million 1,223 741 612 506 487
Y / Y Net Income Change -9.79 % 25.43 % 42.75 % -0.15 % 121.12 %
Net Income in million 92 102 82 57 57
Annual Return On Assets 7.55 % 13.83 % 13.35 % 11.32 % 11.76 %

CBM's 5 Years Annual ROA >> Back to CBM Management Effectiveness >> Compare CBM ROA to its Competitors



Comment on CBM's ROA in the fiscal year ending 2018
In the fiscal year 2018 Cambrex's ROA decreased compared to previous year to 7.55 %, due to deterioration of net income -9.79 % to $92.42 million, from $102.45 million a year ago, as CBM's assets were $1,223.43 million.


More Return On Assets Ratios
CBM's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CBM's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CBM's Competitors
Subscribers only: Roa for Cambrex's Suppliers
Subscribers only: Return On Assets for CBM's Customers

You may also want to know
CBM's Roi CBM's Inventory Turnover Ratio CBM's Growth Rates CBM's Dividend Comparisons
CBM's Profitability Ratios CBM's Asset Turnover Ratio CBM's Dividend Growth
CBM's Roe CBM's Valuation Ratios CBM's Financial Strength Ratios CBM's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2019, within Healthcare Sector ROA
Encompass Health Corporation  7.03 %
Quest Diagnostics Inc  6.68 %
Fuse Medical Inc   6.47 %
Henry Schein Inc   6.47 %
Universal Health Services Inc   6.42 %
Denali Therapeutics Inc   6.04 %
Heartbeam Inc   5.98 %
Steris Plc  5.91 %
National Healthcare Corp  5.78 %
Phibro Animal Health Corporation  5.64 %
Lhc Group Inc   5.61 %
Abbvie Inc   5.60 %
Cryo cell International Inc   5.55 %
Bio rad Laboratories Inc   5.52 %
Charles River Laboratories International inc   5.50 %
Ensign Group Inc  5.49 %
Lifeloc Technologies Inc   5.43 %
Scientific Industries Inc   5.42 %
Xencor Inc  5.38 %
Akorn Inc  5.36 %
Medtronic Plc  5.17 %
Bio techne Corp  5.12 %
Surmodics Inc   4.96 %
Crh Medical Corporation  4.93 %
Staar Surgical Co  4.85 %
Abbott Laboratories  4.85 %
Kyntra Bio Inc   4.81 %
Boston Scientific Corporation  4.75 %
Icu Medical Inc  4.52 %
Addus Homecare Corp  4.44 %

Date modified: 2026-09-08T15:09:41+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.